193 related articles for article (PubMed ID: 21681739)
1. Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors.
Konya V; Philipose S; Bálint Z; Olschewski A; Marsche G; Sturm EM; Schicho R; Peskar BA; Schuligoi R; Heinemann A
Eur J Immunol; 2011 Aug; 41(8):2379-89. PubMed ID: 21681739
[TBL] [Abstract][Full Text] [Related]
2. Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.
Konya V; Üllen A; Kampitsch N; Theiler A; Philipose S; Parzmair GP; Marsche G; Peskar BA; Schuligoi R; Sattler W; Heinemann A
J Allergy Clin Immunol; 2013 Feb; 131(2):532-40.e1-2. PubMed ID: 22704539
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells.
Aso H; Ito S; Mori A; Morioka M; Suganuma N; Kondo M; Imaizumi K; Hasegawa Y
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L266-73. PubMed ID: 22080750
[TBL] [Abstract][Full Text] [Related]
4. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function.
Iyú D; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
Platelets; 2010; 21(5):329-42. PubMed ID: 20433310
[TBL] [Abstract][Full Text] [Related]
5. EP4 receptor stimulation down-regulates human eosinophil function.
Luschnig-Schratl P; Sturm EM; Konya V; Philipose S; Marsche G; Fröhlich E; Samberger C; Lang-Loidolt D; Gattenlöhner S; Lippe IT; Peskar BA; Schuligoi R; Heinemann A
Cell Mol Life Sci; 2011 Nov; 68(21):3573-87. PubMed ID: 21365278
[TBL] [Abstract][Full Text] [Related]
6. Role of PGE
Karaki SI; Tanaka R
J Physiol Sci; 2021 Feb; 71(1):8. PubMed ID: 33622238
[TBL] [Abstract][Full Text] [Related]
7. The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation.
Philipose S; Konya V; Sreckovic I; Marsche G; Lippe IT; Peskar BA; Heinemann A; Schuligoi R
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2416-23. PubMed ID: 21071691
[TBL] [Abstract][Full Text] [Related]
8. Involvement of EP2 and EP4 Receptors in Eosinophilic Esophagitis: A Pilot Study.
Durchschein F; Eherer A; Grill M; Sturm EM; Pommer V; Langner C; Högenauer C; Schicho R
Dig Dis Sci; 2019 Oct; 64(10):2806-2814. PubMed ID: 30989466
[TBL] [Abstract][Full Text] [Related]
9. The EP1/EP3 receptor agonist 17-pt-PGE
Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
11. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
[TBL] [Abstract][Full Text] [Related]
12. PGE1 and PGE2 modify platelet function through different prostanoid receptors.
Iyú D; Jüttner M; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):9-16. PubMed ID: 21095237
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
[TBL] [Abstract][Full Text] [Related]
14. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
[TBL] [Abstract][Full Text] [Related]
15. An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons.
Hayashi Y; Morinaga S; Liu X; Zhang J; Wu Z; Yokoyama T; Nakanishi H
Mediators Inflamm; 2016; 2016():5079597. PubMed ID: 27298516
[TBL] [Abstract][Full Text] [Related]
16. PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptors.
Glenn JR; White AE; Iyu D; Heptinstall S
Platelets; 2012; 23(5):344-51. PubMed ID: 22436052
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
18. Multiple roles of the PGE2 -EP receptor signal in vascular permeability.
Omori K; Kida T; Hori M; Ozaki H; Murata T
Br J Pharmacol; 2014 Nov; 171(21):4879-89. PubMed ID: 24923772
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts.
Noguchi K; Iwasaki K; Shitashige M; Ishikawa I
J Periodontal Res; 1999 Nov; 34(8):478-85. PubMed ID: 10697805
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2-EP3 axis in fine-tuning excessive skin inflammation by restricting dendritic cell functions.
Shiraishi N; Nomura T; Tanizaki H; Nakajima S; Narumiya S; Miyachi Y; Tokura Y; Kabashima K
PLoS One; 2013; 8(7):e69599. PubMed ID: 23922752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
